Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
oregovomab ovarian carcinoma antigen ca125 NA Clinical trial target TTD , DGIDB Malignant neoplasm of ovary[MeSHID:D010051]
Epithelial ovarian cancer[MeSHID:C538090]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 47.74 phase 3 unknown
oregovomab mucin-16 biotech NA drugbank , DGIDB Malignant neoplasm of ovary[MeSHID:D010051]
Epithelial ovarian cancer[MeSHID:C538090]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 47.74 investigational unknown
click here to return to the previous page